Loss of T Cell CD98 H Chain Specifically Ablates T Cell Clonal Expansion and Protects from Autoimmunity
Open Access
- 15 July 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (2) , 851-860
Abstract
CD98 H chain (4F2 Ag, Slc3a2) was discovered as a lymphocyte-activation Ag. Deletion of CD98 H chain in B cells leads to complete failure of B cell proliferation, plasma cell formation, and Ab secretion. In this study, we examined the role of T cell CD98 in cell-mediated immunity and autoimmune disease pathogenesis by specifically deleting it in murine T cells. Deletion of T cell CD98 prevented experimental autoimmune diabetes associated with dramatically reduced T cell clonal expansion. Nevertheless, initial T cell homing to pancreatic islets was unimpaired. In sharp contrast to B cells, CD98-null T cells showed only modestly impaired Ag-driven proliferation and nearly normal homeostatic proliferation. Furthermore, these cells were activated by Ag, leading to cytokine production (CD4) and efficient cytolytic killing of targets (CD8). The integrin-binding domain of CD98 was necessary and sufficient for full clonal expansion, pointing to a role for adhesive signaling in T cell proliferation and autoimmune disease. When we expanded CD98-null T cells in vitro, they adoptively transferred diabetes, establishing that impaired clonal expansion was responsible for protection from disease. Thus, the integrin-binding domain of CD98 is required for Ag-driven T cell clonal expansion in the pathogenesis of an autoimmune disease and may represent a useful therapeutic target.Keywords
This publication has 54 references indexed in Scilit:
- Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)Journal of Experimental Medicine, 2009
- Autoimmune T cell responses in the central nervous systemNature Reviews Immunology, 2009
- Cutting Edge: A Critical Role of B and T Lymphocyte Attenuator in Peripheral T Cell Tolerance InductionThe Journal of Immunology, 2009
- CD98hc facilitates B cell proliferation and adaptive humoral immunityNature Immunology, 2009
- Genetic Deficiency of Itgb2 or ItgaL Prevents Autoimmune Diabetes Through Distinctly Different Mechanisms in NOD/LtJ MiceDiabetes, 2009
- CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signalingJournal of Cell Biology, 2007
- Islet β-Cell-Specific T Cells Can Use Different Homing Mechanisms to Infiltrate and Destroy Pancreatic IsletsThe American Journal of Pathology, 2007
- The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectationsJournal of Autoimmunity, 2004
- Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejectionExpert Opinion on Biological Therapy, 2003
- Monocyte-dependent regulation of T lymphocyte activation through CD98International Immunology, 1997